Key in Biological Technology

Digitas Health Expands Adding Two Key Locations

PHILADELPHIA, July 27 /PRNewswire/ -- Digitas Health, Medical Marketing & Media magazine's 2009 Agency of the Year, today announces the opening of two key new locations in London and Boston. This move is a strategic part of the agency's 2010 growth plan. Digitas Health has ...

Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing

MADISON, Wis., July 15 /PRNewswire/ -- Cellular Dynamics International (CDI) today announced that it has exclusively in-licensed a US-issued patent portfolio on optimizing the stem cell differentiation selection process and on using heart cells (cardiomyocytes) in drug testing...

Mirixa Corporation Announces Key New Hires

RESTON, Va., July 9 /PRNewswire/ -- Mirixa Corporation, the leader in targeted pharmacy-based patient care services, today announced the hiring of three new members to its growing pharmacy team. Mirixa welcomes Joseph Gruber, RPh, CGP, FASCP, Kim Swiger, RPh, and Paul Miller, MS, RPh. Each n...

Stem cells' 'suspended' state preserved by key step, scientists report

Scientists have identified a gene that is essential for embryonic stem cells to maintain their all-purpose, pluripotent state. Exploiting the finding may lead to a greater understanding of how cells acquire their specialized states and provide a strategy to efficiently reprogram mature cells back...

Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels

SAO PAULO, June 23 /PRNewswire/ -- What does sugarcane have to do with Global Warming? Everything, when you consider Brazil's highly successful, 30-year experience with sugarcane as a feedstock for ethanol. In place since the mid-70s, the largest program in the world to replace a fossil fuel w...

Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood-Based Tests for Key Cancer Mutations

NEW YORK, June 22 /PRNewswire/ -- Exosome Diagnostics, Inc. ("ExosomeDX") and DxS Ltd. ("DxS") today announced that they will collaborate on the development of blood-based companion diagnostics for key cancer gene mutations, such as KRAS, BRAF and EGFR. The collaboration will use DxS' industry le...

Tobira Therapeutics Inc. Announces Key Addition to Scientific Advisory Board

- Dr. Roscoe M. Moore, Jr. to join Board - PRINCETON, N.J. and SAN DIEGO, June 4 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the...

GenVault Receives Four Critical U.S. and E.U. Patent Allowances for Key Biosample Management Technologies

CARLSBAD, Calif., May 20 /PRNewswire/ -- GenVault Corporation is pleased to announce notice of allowance for four key patents in its growing portfolio. U.S. Patent Application #10/005,415, entitled "Automated Biological Sample Archive for Storage, Retrieval & Analysis of a Large Number of Sa...

In Eleventh-Hour Smear Attempt, Quigley Management Sacrifices Key Employee of its Pharma Division

WOODMERE, N.Y., May 19 /PRNewswire/ -- In an eleventh-hour attempt to smear Ted Karkus, The Quigley Corporation (Nasdaq: QGLY ) has issued a press release claiming that there was some improper financial arrangement between Dr. Richard Rosenbloom, a key staff member of a subsidiary of Quigley, ...

Avoiding False Positives Key Priority in Cardiac Safety Studies

Pharmaceutical Companies Recognizing Risks with Traditional Cardiac Safety Approaches Rochester, NY (PRWEB) May 4, 2009 -- iCardiac Technologies, Inc., a leading innovator in advanced cardiac safety biomarkers and automated QT analysis, today announced the results of it...

Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments

- First HGS product sales achieved with delivery of ABthrax(TM) to U.S. Strategic National Stockpile - - $177 million in first quarter revenues; cash balance of $397 million as of March 31, up $24 million from year-end 2008 - - Positive results for second Phase 3 trial of Albuferon (R...

Sinobiopharma Secures Rights to Seven Key Patents

NANJING, China, April 27 /PRNewswire-FirstCall/ -- Sinobiopharma Inc. ("Sinobiopharma ", or "the Company") (OTC Bulletin Board: SNBP) is pleased to announce that it has secured rights to seven key patents from Company CEO Dr. Lequn Huang and the patents' co-holders. The patents that will significa...

PRA International Presents Key Budgeting Strategies at 18th Annual CRO Partnerships Conference

RALEIGH, N.C., April 23 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces it will present during the Partnerships with CRO 18th Annual Meeting April 28-30, 2009 in Orlando Florida. PRA's Greg Guarasci, Senior Vice President - General Partner will present " RFP ...

Genomic Study Shows Organic Skin Care Product Activates Key Anti-Aging Gene

A recent study using state-of-the-art genetic testing shows that an all natural skin care product called Ambra-Lift™ by Elina™ Organics activates Sirtuin-1, a key anti-aging gene. Until now only Resveratrol, a substance found in the skin of grapes and red wine, has been known to ...

Intradigm Receives Notice of Allowance for Key RNA Interference (RNAi) Patent Covering Potent siRNA Sequence

Issuance Will Give Company Patents in Each of the Three Critical Areas of RNAi Therapeutic Development PALO ALTO, Calif., March 17 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced that the United States Pate...

Localization and Translation Leader CSOFT International Ltd. Recognizes Efforts of Two Key Members of its Business Development Team

CSOFT Promotes Matt Arney to Vice President and Helena Rojas to Director of Global Business Development Operations Beijing, China (PRWEB) March 5, 2009 -- CSOFT International Ltd., a leading provider of multilingual localization, testing and outsourced software developm...

Web-based Audio Interviews Keep Environment of Care Managers Up-to-Date on Key EC Compliance Issues

NEEDHAM, Mass., Feb. 24 /PRNewswire/ -- Environment of Care managers can now quickly and easily access practical tips to better achieve and maintain their organization's environment of care (EC) compliance with the launch of a new series of brief, web-based audio interviews with EC experts cal...

Cheaper materials could be key to low-cost solar cells

Berkeley -- Unconventional solar cell materials that are as abundant but much less costly than silicon and other semiconductors in use today could substantially reduce the cost of solar photovoltaics, according to a new study from the Energy and Resources Group and the Department of Chemistry at t...

Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials

BOSTON, Jan. 29 /PRNewswire-FirstCall/ -- Perceptive Informatics (Perceptive), the industry's leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL ), today announced that it has reached a key milestone, with 10 million calls placed through it...

Scientists publish complete genetic blueprint of key biofuels crop

WALNUT CREEK, Calif.-- Scientists at the U.S. Department of Energy (DOE) Joint Genome Institute (JGI) and several partner institutions have published the sequence and analysis of the complete genome of sorghum, a major food and fodder plant with high potential as a bioenergy crop. The genome data...

Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement

Milestone Achieved A Year Ahead of Schedule ST. LOUIS and RICHMOND, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced it has reached a major production capacity milestone as part of its agreement with Sigma-Aldrich Corporation (Nasdaq: SI...

Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints

SAN DIEGO, Jan. 8 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ) today announced that the first of four Phase 3 trials of its lead investigational product Contrave(R) (naltrexone sustained release (SR)/bupropion SR) met its co-primary and key secondary endpoints, sh...

Sangart, Inc. Announces Key Executive Appointments and Company Restructuring

SAN DIEGO, Jan. 7 /PRNewswire/ -- Sangart, Inc., a privately held biopharmaceutical company focused on the research, development and commercialization of oxygen-therapeutic agents, today announced a company restructuring that includes the addition of four key leadership positions and a signifi...

Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)

SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced that the United States Patent and Trademark Office (USPTO) has issued a patent for what the Company refers to as the "W...

AARC Presentation Cites Masimo Patient SafetyNet as Key Factor in 'Improving Patient Outcomes and Reducing Costs' in Post-Acute Care Facilities

Masimo also receives the AARC Zenith Award for Equipment and Service Excellence at the 54th Annual International Respiratory Congress in Anaheim IRVINE, Calif., Dec. 16 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI ), the inventor of Pulse CO-Oximetry and Measure-Through-Motion and Low...

Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics

PALO ALTO, Calif., Dec. 2 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced the issuance of United States patent 7,459,547, entitled "Methods and Compositions for Controlling Efficacy of RNA Silencing." The issue...

Fast molecular rearrangements hold key to plastic's toughness

MADISON -- Plastics are everywhere in our modern world, largely due to properties that render the materials tough and durable, but lightweight and easily workable. One of their most useful qualities, however - the ability to bend rather than break when put under stress - is also one of the most pu...

Fast molecular rearrangements hold key to plastic’s toughness

MADISON -- Plastics are everywhere in our modern world, largely due to properties that render the materials tough and durable, but lightweight and easily workable. One of their most useful qualities, however - the ability to bend rather than break when put under stress - is also one of the most pu...

Arpida to Restructure and Focus on Key Projects

REINACH, Switzerland, November 27 /PRNewswire-FirstCall/ -- Arpida announced today that it is refocusing all projects and priorities around the key strategic asset Iclaprim. The company says this is to be seen as a consequence of the negative recommendation of the U.S. Food and Drug Administra...

Diagnostic Imaging to Deliver Its 11th Annual Webcast of Key Events Taking Place at RSNA 2008

SAN FRANCISCO, Nov. 24 /PRNewswire/ -- Diagnostic Imaging will produce its 11th Annual Webcast From the RSNA based on proceedings from the upcoming Radiology Society of North America Scientific Assembly and Annual Meeting taking place in Chicago, IL, from November 30th through December 5th. This ...

MiddleBrook Pharmaceuticals Hires Key Commercial Team Members

Company prepares to launch Moxatag(TM), the first and only FDA-approved once-daily amoxicillin, in the first quarter of 2009 GERMANTOWN, Md., Nov. 19 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK ), today announced it has hired the following key commercial te...

RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research

DNA2.0 has designed RNAi-resistant genes that enabled a breakthrough in understanding the inner workings of the cell cycle. DNA2.0's RNAissance genes are simultaneously optimized for expression in the desired host and to escape inhibition by siRNA that is targeted to the natural gene. ...

Max Planck Institute of Biochemistry Uses MathWorks Tools in Its Quest to Cure Cancer : Institute Accelerates Reconstruction of Key Protein Complexes Using MATLAB and Parallel Computing Toolbox

The MathWorks today announced that the Max Planck Institute of Biochemistry is using MATLAB, Parallel Computing Toolbox, MATLAB Distributed Computing Server, and other MathWorks tools to accelerate its workflow and drastically reduce research and development time. NATI...

Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments

- Treatment completed in Albuferon(R) Phase 3 trials; first Phase 3 data in December 2008 - - Enrollment completed in LymphoStat-B(R) Phase 3 trials; first Phase 3 data in mid-2009 - - HGS updates financial guidance - ROCKV...

New Study Provides Key Findings for Biopharma Product Launch Evaluation

CHAPEL HILL, N.C., Nov. 5 /PRNewswire/ -- As biopharmaceutical companies continue to bring new therapies to market, considerable efforts are placed on strategy and execution from development through launch, while post-launch evaluations largely focus on revenue growth and little else. In a con...

PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress

BOSTON, Nov. 3 /PRNewswire-FirstCall/ -- Albert Liou, Corporate Vice President and General Manager, Asia-Pacific Region, at PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, will present "What Can China Really Deliver in Terms of Cost and...

Sea urchin yields a key secret of biomineralization

MADISON The teeth and bones of mammals, the protective shells of mollusks, and the needle-sharp spines of sea urchins and other marine creatures are made-from-scratch wonders of nature. Used to crush food, for structural support and for defense, the materials of which shells, teeth and bones a...

Memoirs of a qubit: Hybrid memory solves key problem for quantum computing

An international team of scientists has performed the ultimate miniaturisation of computer memory: storing information inside the nucleus of an atom. This breakthrough is a key step in bringing to life a quantum computer - a device based on the fundamental theory of quantum mechanics which could c...

NanoBio to Announce Key Clinical and Preclinical Data in Nine Presentations at ICAAC/IDSA 2008

Findings confirm that NanoBio's nanoemulsion technology is effective when used in therapeutic applications and vaccines ANN ARBOR, Mich., Oct. 21 /PRNewswire/ -- NanoBio Corporation announced today that it will present compelling new data in nine presentations that detail key milest...

Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder

SAN CARLOS, Calif., Oct. 21 /PRNewswire-FirstCall/ -- (11:00 PM PT, Oct. 20) -- Nektar Therapeutics (Nasdaq: NKTR ) today announced that Novartis AG has agreed to acquire from Nektar specific pulmonary delivery assets, technology, and intellectual property for $115 million in cash. "This ag...